Active Ingredient: NEVIRAPINE
Proprietary Name: VIRAMUNE XR
Dosage Form; Route of Administration: TABLET, EXTENDED RELEASE; ORAL
Strength: 400MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N201152
Product Number: 001
Approval Date: Mar 25, 2011
Applicant Holder Full Name: BOEHRINGER INGELHEIM PHARMACEUTICALS INC
Marketing Status:
Prescription
Patent and Exclusivity Information
